+ All Categories
Home > Documents > General Chapter Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals)....

General Chapter Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals)....

Date post: 04-Jul-2020
Category:
Upload: others
View: 7 times
Download: 0 times
Share this document with a friend
44
General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging Type of Posting Revision Bulletin Posting Date 29–May–2020 Official Date 01–Dec–2020 Expert Committee Chemical Medicines Monographs 4 Reason for Revision Compliance – Appeals Panel Decision In accordance with the Rules and Procedures of the 2015–2020 Council of Experts, the Chemical Medicines Monographs 4 (CHM4) Expert Committee is reinstating the official date of General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging, following the resolution of an appeal related to the chapter. After publication of General Chapter <825> on June 1, 2019, with an anticipated official date of December 1, 2019, USP received an appeal related to the chapter, necessitating the postponement of the original official date pending appeal resolution. In accordance with the formal appeals process set forth in USP’s Bylaws, the responsible Expert Committee (CHM4) worked with a sense of urgency to consider the information raised in the appeal and issued a decision denying the appeal (see Decision on Appeal to USP <825>). The appellant requested further review of the appeal by an appointed Panel, and the Panel ultimately denied the appeal (see Appeals Panel Decisions). Based on the final decision of the Appeals Panel, the CHM4 Expert Committee has decided to lift the postponement and to establish a new official date of December 1, 2020. When General Chapter <825> becomes official, it will be informational unless otherwise required by a regulatory body. This is because revisions to General Chapters <795> and <797>, published on June 1, 2019, which contained cross-references that would have made <825> compendially applicable, were remanded by the USP Appeals Panel. The currently official versions of <795> and <797> do not contain cross-references to <825> (see Role and Applicability of USP General Chapter <825> Related to Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the chapter to help ensure a safe environment and protection of healthcare practitioners and others when handling radiopharmaceuticals. Should you have any questions, please contact Ravi Ravichandran, Principal Scientific Liaison (301-816- 8330 or [email protected]). C263975-M11915-CHM42015, rev. 00 20200529
Transcript
Page 1: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging

Type of Posting Revision Bulletin Posting Date 29–May–2020Official Date 01–Dec–2020Expert Committee Chemical Medicines Monographs 4 Reason for Revision Compliance – Appeals Panel Decision

In accordance with the Rules and Procedures of the 2015–2020 Council of Experts, the Chemical Medicines Monographs 4 (CHM4) Expert Committee is reinstating the official date of General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging, following theresolution of an appeal related to the chapter.

After publication of General Chapter <825> on June 1, 2019, with an anticipated official date of December 1, 2019, USP received an appeal related to the chapter, necessitating the postponement of the original official date pending appeal resolution.

In accordance with the formal appeals process set forth in USP’s Bylaws, the responsible Expert Committee (CHM4) worked with a sense of urgency to consider the information raised in the appeal and issued a decision denying the appeal (see Decision on Appeal to USP <825>).

The appellant requested further review of the appeal by an appointed Panel, and the Panel ultimately denied the appeal (see Appeals Panel Decisions). Based on the final decision of the Appeals Panel, the CHM4 Expert Committee has decided to lift the postponement and to establish a new official date of December 1, 2020.

When General Chapter <825> becomes official, it will be informational unless otherwise required by a regulatory body. This is because revisions to General Chapters <795> and <797>, published on June 1, 2019, which contained cross-references that would have made <825> compendially applicable, were remanded by the USP Appeals Panel. The currently official versions of <795> and <797> do not contain cross-references to <825> (see Role and Applicability of USP General Chapter <825> Related to Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the chapter to help ensure a safe environment and protection of healthcare practitioners and others when handling radiopharmaceuticals.

Should you have any questions, please contact Ravi Ravichandran, Principal Scientific Liaison (301-816-8330 or [email protected]).

C263975-M11915-CHM42015, rev. 00 20200529

Page 2: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

� �

C263975-M11915-CHM42015, rev. 00 20200529

Page 3: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 4: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 5: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 6: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 7: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 8: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 9: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 10: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 11: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 12: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 13: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 14: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 15: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 16: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 17: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 18: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 19: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 20: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 21: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 22: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 23: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 24: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 25: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 26: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 27: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 28: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 29: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 30: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 31: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 32: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 33: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 34: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 35: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 36: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 37: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 38: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 39: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 40: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 41: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 42: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 43: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529

Page 44: General Chapter  Radiopharmaceuticals – Preparation ......May 29, 2020  · Radiopharmaceuticals). USP continues to encourage early adoption and implementation of the

C263975-M11915-CHM42015, rev. 00 20200529


Recommended